Published in Maturitas on January 20, 2006
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt) (2013) 0.95
Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid (2009) 0.94
Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol (2008) 0.93
Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril (2009) 0.89
Joint effects of smoking and gene variants involved in sex steroid metabolism on hot flashes in late reproductive-age women. J Clin Endocrinol Metab (2012) 0.88
Race and health-related quality of life in midlife women in Baltimore, Maryland. Maturitas (2009) 0.85
Endogenous hormones, participant characteristics, and symptoms among midlife women. Maturitas (2008) 0.85
Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) (2010) 0.83
Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study. Menopause (2015) 0.83
Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes. Am J Obstet Gynecol (2012) 0.81
The Association between Body Mass Index and Hot Flash in Midlife Women: A Meta-analysis. J Menopausal Med (2016) 0.80
Current alcohol use, hormone levels, and hot flashes in midlife women. Fertil Steril (2007) 0.78
Does quitting smoking decrease the risk of midlife hot flashes? A longitudinal analysis. Maturitas (2015) 0.77
Phthalate metabolite levels and menopausal hot flashes in midlife women. Reprod Toxicol (2016) 0.76
Hot flashes and blood pressure in midlife women. Maturitas (2009) 0.76
A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes. Menopause (2015) 0.76
Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors. Psychosom Med (2015) 0.75
Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol (2011) 2.99
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol (2008) 2.60
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med (2012) 2.45
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A (2011) 2.12
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis (2007) 1.91
Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut (2012) 1.66
Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol (2003) 1.63
Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61
BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development (2003) 1.55
Body mass and stage of breast cancer at diagnosis. Int J Cancer (2002) 1.54
Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol (2012) 1.46
Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res (2005) 1.46
Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway. Toxicol Sci (2006) 1.40
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem (2013) 1.31
Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem (2012) 1.29
Methoxychlor metabolites may cause ovarian toxicity through estrogen-regulated pathways. Toxicol Sci (2006) 1.28
Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol (2002) 1.28
Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst (2009) 1.26
Bisphenol A impairs follicle growth, inhibits steroidogenesis, and downregulates rate-limiting enzymes in the estradiol biosynthesis pathway. Toxicol Sci (2010) 1.26
The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol (2008) 1.25
Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol (2005) 1.25
Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics. J Oncol (2010) 1.24
Methoxychlor directly affects ovarian antral follicle growth and atresia through Bcl-2- and Bax-mediated pathways. Toxicol Sci (2005) 1.24
Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol (2005) 1.22
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr (2012) 1.21
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis (2012) 1.20
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res (2014) 1.19
Multilocus analysis of age-related macular degeneration. Eur J Hum Genet (2009) 1.18
Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod (2002) 1.17
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.16
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res Treat (2011) 1.15
Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol (2012) 1.13
Acute and chronic effects of oral genistein administration in neonatal mice. Biol Reprod (2010) 1.12
Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) (2003) 1.12
Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw (2015) 1.12
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.11
Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev (2011) 1.11
Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med (2002) 1.11
Differences between rats and mice in the involvement of the aryl hydrocarbon receptor in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss. Toxicol Appl Pharmacol (2005) 1.10
Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicol Appl Pharmacol (2011) 1.09
Association between race and hot flashes in midlife women. Maturitas (2006) 1.08
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol (2005) 1.08
Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control (2010) 1.08
Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol (2011) 1.07
Physical activity and risk of hot flashes among women in midlife. J Womens Health (Larchmt) (2007) 1.07
Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer (2007) 1.07
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. J Oncol (2010) 1.07
Ovarian follicle development requires Smad3. Mol Endocrinol (2004) 1.06
Depressive symptoms and self-reported fast-food intake in midlife women. Prev Med (2011) 1.06
Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol (2010) 1.05
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Hum Gene Ther (2004) 1.05
Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicol Appl Pharmacol (2009) 1.05
Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDS (2005) 1.04
Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril (2006) 1.04
Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol (2003) 1.03
Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer. Cancer Biol Ther (2007) 1.02
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas (2009) 1.02
A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care (2011) 1.02
Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction (2011) 1.01
Methoxychlor-induced atresia in the mouse involves Bcl-2 family members, but not gonadotropins or estradiol. Biol Reprod (2004) 1.00
Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 0.99
Bisphenol A inhibits follicle growth and induces atresia in cultured mouse antral follicles independently of the genomic estrogenic pathway. Biol Reprod (2012) 0.99
In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol (2004) 0.98
The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness. Biol Reprod (2007) 0.98
Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res (2007) 0.98
No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. Prostate (2004) 0.96
Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study. Am J Epidemiol (2011) 0.96
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma. Mod Pathol (2011) 0.96
Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study. Cancer Causes Control (2013) 0.96
Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett (2005) 0.95
Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biol Reprod (2002) 0.95
Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Cancer (2009) 0.95
NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res B Dev Reprod Toxicol (2006) 0.95
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol (2014) 0.95